Department of Otolaryngology, Head and Neck Surgery, Tel Aviv Sourasky Medical Center, 6 Weizmann St, Tel Aviv, 64239, Israel.
J Natl Cancer Inst. 2010 Jan 20;102(2):107-18. doi: 10.1093/jnci/djp456. Epub 2010 Jan 12.
The ability of cancer to infiltrate along nerves is a common clinical observation in pancreas, head and neck, prostate, breast, and gastrointestinal carcinomas. For these tumors, nerves may provide a conduit for local cancer progression into the central nervous system. Although neural invasion is associated with poor outcome, the mechanism that triggers it is unknown.
We used an in vitro Matrigel dorsal root ganglion and pancreatic cancer cell coculture model to assess the dynamic interactions between nerves and cancer cell migration and the role of glial cell-derived neurotrophic factor (GDNF). An in vivo murine sciatic nerve model was used to study how nerve invasion affects sciatic nerve function.
Nerves induced a polarized neurotrophic migration of cancer cells (PNMCs) along their axons, which was more efficient than in the absence of nerves (migration distance: mean = 187.1 microm, 95% confidence interval [CI] = 148 to 226 microm vs 14.4 microm, 95% CI = 9.58 to 19.22 microm, difference = 143 microm; P < .001; n = 20). PNMC was induced by secretion of GDNF, via phosphorylation of the RET-Ras-mitogen-activated protein kinase pathway. Nerves from mice deficient in GDNF had reduced ability to attract cancer cells (nerve invasion index: wild type vs gdnf+/-, mean = 0.76, 95% CI = 0.75 to 0.77 vs 0.43, 95% CI = 0.42 to 0.44; P < .001; n = 60-66). Tumor specimens excised from patients with neuroinvasive pancreatic carcinoma had higher expression of the GDNF receptors RET and GRFalpha1 as compared with normal tissue. Finally, systemic therapy with pyrazolopyrimidine-1, a tyrosine kinase inhibitor targeting the RET pathway, suppressed nerve invasion toward the spinal cord and prevented paralysis in mice.
These data provide evidence for paracrine regulation of pancreatic cancer invasion by nerves, which may have important implications for potential therapy directed against nerve invasion by cancer.
癌症沿着神经浸润的能力是胰腺、头颈部、前列腺、乳腺和胃肠道癌的常见临床观察。对于这些肿瘤,神经可能为局部癌症向中枢神经系统进展提供了一个途径。尽管神经侵犯与不良预后相关,但触发它的机制尚不清楚。
我们使用体外 Matrigel 背根神经节和胰腺癌细胞共培养模型来评估神经与癌细胞迁移之间的动态相互作用,以及胶质细胞衍生的神经营养因子(GDNF)的作用。使用体内鼠坐骨神经模型来研究神经侵犯如何影响坐骨神经功能。
神经诱导癌细胞(PNMC)沿着其轴突产生极化的神经营养性迁移,其效率高于没有神经的情况(迁移距离:平均值=187.1 微米,95%置信区间[CI] = 148 至 226 微米与 14.4 微米,95%CI = 9.58 至 19.22 微米,差异=143 微米;P <.001;n = 20)。PNMC 是通过 RET-Ras-丝裂原活化蛋白激酶途径的磷酸化来分泌 GDNF 诱导的。缺乏 GDNF 的神经对癌细胞的吸引力降低(神经侵犯指数:野生型与 gdnf +/-, 平均值=0.76,95%CI = 0.75 至 0.77 与 0.43,95%CI = 0.42 至 0.44;P <.001;n = 60-66)。从患有神经侵袭性胰腺癌的患者切除的肿瘤标本与正常组织相比,GDNF 受体 RET 和 GRFalpha1 的表达更高。最后,系统给予靶向 RET 通路的吡唑并嘧啶-1(一种酪氨酸激酶抑制剂)治疗,抑制了向脊髓的神经侵犯并防止了小鼠瘫痪。
这些数据为神经对胰腺癌细胞侵袭的旁分泌调节提供了证据,这可能对针对癌症神经侵犯的潜在治疗具有重要意义。